Suppr超能文献

阐明 mWT1 肿瘤相关抗原肽与 HLA-A*24:02 之间的结合机制、亲和力和复合物结构。

Elucidation of binding mechanism, affinity, and complex structure between mWT1 tumor-associated antigen peptide and HLA-A*24:02.

机构信息

Institute for Protein Research, Osaka University, Suita, Osaka, Japan.

Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

出版信息

Protein Sci. 2023 Oct;32(10):e4775. doi: 10.1002/pro.4775.

Abstract

We have applied our advanced computational and experimental methodologies to investigate the complex structure and binding mechanism of a modified Wilms' Tumor 1 (mWT1) protein epitope to the understudied Asian-dominant allele HLA-A*24:02 (HLA-A24) in aqueous solution. We have applied our developed multicanonical molecular dynamics (McMD)-based dynamic docking method to analyze the binding pathway and mechanism, which we verified by comparing the highest probability structures from simulation with our experimentally solved x-ray crystal structure. Subsequent path sampling MD simulations elucidated the atomic details of the binding process and indicated that first an encounter complex is formed between the N-terminal's positive charge of the 9-residue mWT1 fragment peptide and a cluster of negative residues on the surface of HLA-A24, with the major histocompatibility complex (MHC) molecule preferring a predominantly closed conformation. The peptide first binds to this closed MHC conformation, forming an encounter complex, after which the binding site opens due to increased entropy of the binding site, allowing the peptide to bind to form the native complex structure. Further sequence and structure analyses also suggest that although the peptide loading complex would help with stabilizing the MHC molecule, the binding depends in a large part on the intrinsic affinity between the MHC molecule and the antigen peptide. Finally, our computational tools and analyses can be of great benefit to study the binding mechanism of different MHC types to their antigens, where it could also be useful in the development of higher affinity variant peptides and for personalized medicine.

摘要

我们应用先进的计算和实验方法来研究一个经过修饰的 Wilms' Tumor 1(mWT1)蛋白表位与在研的亚洲优势等位基因 HLA-A*24:02(HLA-A24)在水溶液中的复杂结构和结合机制。我们应用我们开发的多正则分子动力学(McMD)为基础的动态对接方法来分析结合途径和机制,通过将模拟中最高概率的结构与我们实验解决的 X 射线晶体结构进行比较,我们验证了这一点。随后的路径采样 MD 模拟阐明了结合过程的原子细节,并表明首先在 HLA-A24 表面形成一个带正电荷的 9 个残基 mWT1 片段肽的 N 端和一个负电荷簇之间形成一个遭遇复合物,主要组织相容性复合物(MHC)分子更喜欢一个主要关闭的构象。肽首先与这种封闭的 MHC 构象结合,形成一个遭遇复合物,然后由于结合位点的熵增加,结合位点打开,允许肽结合形成天然复合物结构。进一步的序列和结构分析还表明,尽管肽加载复合物有助于稳定 MHC 分子,但结合在很大程度上取决于 MHC 分子和抗原肽之间的固有亲和力。最后,我们的计算工具和分析可以极大地有助于研究不同 MHC 类型与它们的抗原的结合机制,这也可能对开发更高亲和力的变异肽和个性化医学有用。

相似文献

3
Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics.
Mol Immunol. 2010 Sep;47(15):2519-24. doi: 10.1016/j.molimm.2010.06.005. Epub 2010 Jul 8.
7
Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24 allele.
Microb Pathog. 2012 Sep;53(3-4):162-7. doi: 10.1016/j.micpath.2012.07.002. Epub 2012 Jul 20.
9
Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm.
Cancer Sci. 2011 Apr;102(4):690-6. doi: 10.1111/j.1349-7006.2011.01866.x. Epub 2011 Feb 20.

引用本文的文献

1
The potential applications of peptide-loading complex in cancer treatment.
Front Immunol. 2025 Mar 3;16:1526137. doi: 10.3389/fimmu.2025.1526137. eCollection 2025.
2
Binding Mechanism of Riboswitch to Natural Ligand Elucidated by McMD-Based Dynamic Docking Simulations.
ACS Omega. 2024 Jan 10;9(3):3412-3422. doi: 10.1021/acsomega.3c06826. eCollection 2024 Jan 23.

本文引用的文献

1
The landscape of T cell antigens for cancer immunotherapy.
Nat Cancer. 2023 Jul;4(7):937-954. doi: 10.1038/s43018-023-00588-x. Epub 2023 Jul 6.
3
Advancing the field of computational drug design using multicanonical molecular dynamics-based dynamic docking.
Biophys Rev. 2022 Nov 19;14(6):1349-1358. doi: 10.1007/s12551-022-01010-z. eCollection 2022 Dec.
4
Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors.
J Immunol. 2022 Nov 1;209(9):1652-1661. doi: 10.4049/jimmunol.2200191. Epub 2022 Sep 21.
5
Structure of an MHC I-tapasin-ERp57 editing complex defines chaperone promiscuity.
Nat Commun. 2022 Sep 14;13(1):5383. doi: 10.1038/s41467-022-32841-9.
9
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons.
Front Immunol. 2021 Mar 30;12:658753. doi: 10.3389/fimmu.2021.658753. eCollection 2021.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验